Clinical studies on a newly devised amino acid solution for neonates

Area of Science:

• Neonatal Medicine
• Nutritional Biochemistry
• Pediatric Surgery

Background:

• Total parenteral nutrition (TPN) is crucial for postoperative neonates.
• Standard amino acid solutions may not optimize plasma amino acid profiles in this population.
• A novel amino acid solution, PF-I-III, was developed to address these limitations.

Purpose of the Study:

• To clinically assess a new amino acid solution (PF-I-III) in postoperative neonates.
• To evaluate the plasma amino acid profile and nutritional effects of PF-I-III.
• To determine optimal amino acid dosages for neonatal TPN.

Main Methods:

• Clinical assessment of 97 neonates receiving TPN with PF-I-III.
• Analysis of plasma amino acid profiles.
• Comparison of PF-I-III composition with commercially available solutions.
• Dose-response correlation between administered amino acids and plasma levels.

Main Results:

• PF-I-III features higher branched-chain amino acids (40%), increased arginine, and decreased glycine, phenylalanine, and methionine.
• The PF group maintained amino acids within standard ranges.
• Established minimum, standard, and maximum doses for each amino acid.
• No abnormal plasma amino acid patterns were observed even at 1.5-2.5 g/kg/day.

Conclusions:

• The novel PF-I-III amino acid formula is safe and effective for neonatal TPN.
• This formulation supports normal plasma amino acid homeostasis in postoperative neonates.
• The determined dosage ranges provide a basis for optimized neonatal nutritional therapy.